Biocon starts clinical trial of drug meant to treat Ulcerative Colitis in India
On Wednesday, Biocon Limited and biopharmaceutical company Equillium Inc. jointly announced the start of a clinical trial using the monoclonal antibody Itolizumab in patients with...